HCG is an international scientific agency consisting of 9 companies: Accuverus, Chameleon Communications International, Health Science Communications, Health Science Communications NJ, Hyphen Digital, ProEd Communications, ProEd Regulatory, The Scienomics Group, and Scientific Strategy Partners. With offices in New York City, New Jersey, Connecticut, San Francisco, London, and Manchester; and access to Omnicom affiliates in Latin America, Western Europe, and Pan-Asia; we provide solutions for your global pharmaceutical affairs. HCG has over 350 employees, with over 90 of them holding advanced degrees, either MDs, PhDs, or PharmDs.
Our scientists and account teams are smart, strategic, and creative. Our creative teams understand how to present complex data in an impactful way, making it beautiful, engaging, and relevant. Our editors, traffic, programmers, and project managers strive to ensure the work we produce for you is flawless. Our finance team partners with all the groups to ensure we are tracking and staying within budget. Most importantly, senior management—CEO, presidents, EVPs, and managing directors—are intimately involved in your work.
We embrace diversity and encourage people to speak up, we love competition and a fair fight, and we are not intimidated by a difficult challenge—we are inspired. We believe in success and we humbly accept our failures, but there is one thing we will not tolerate—and that is not trying.
We are full service but with focus. Our focus is on scientific positioning and branding, both visual and written, and developing succinct impactful messages, content, and programming supported by data that can be used in communications with the FDA and EMA, healthcare professionals, patients, and your other partners. This saves you time and money. We have a regulatory practice, taking over 90 drugs to committee with an 80% positive response, and a publications group that boasts over 1500 publications with an overall acceptance rate of 90%. We develop scientific strategy and communications, including disease education, MOA and MOD animations, creative booth content for congresses, and unbranded and branded live or Web-based peer to peer communications for specialists. We are not a digital agency but a scientific agency that is digitally infused; this way your content is right the first time, making MLR a walk in the park. We are a scientifically rigorous, strategically focused, creatively balanced agency built for the future.
We invite you to visit the HCG Group company websites by accessing the links below.
Denise Bottiglieri, PhD
Chief Executive Officer, Healthcare Consultancy Group
Denise received her PhD in pharmacology from the University of Florida and her postdoctoral training in clinical pharmacology from Vanderbilt University. She accepted a position at Pfizer Pharmaceuticals in New York, where she was responsible for the design and execution of clinical trials. It was at Pfizer that Denise first learned about healthcare communications and education; she was intrigued by the intersection of science, medicine, and communications.
Denise was introduced to Diversified Agency Services, the specialty marketing group of Omnicom, and took a position at Health Science Communications, beginning her career in healthcare communications and at Diversified Agency Services, where she is currently and has been for 20 years.
Denise is the CEO of the Healthcare Consultancy Group (HCG), a group of companies with serious expertise in global digital strategy, regulatory consulting, publication planning, and educational and promotional communications and strategy within the pharmaceutical and medical device space. She works to protect the integrity of the science and data above all else, is passionate about creating best-in-class teams that provide value to clients, and believes that every client is different, every problem has a solution, and well done is better than well said.
The companies in HCG serve both large pharma and biotech start-ups. Paying particular attention to the large differences and the small nuances of each client is critical to maintaining a long-term partnership and trust, but understanding that the true client is the drug is what differentiates HCG from other healthcare companies.
Denise volunteers for the Azama Project building schools in Ecuador for the indigenous people. She is an avid boxing fan (the sweet science—not UFC) and at one time wanted to be a physicist, but Maxwell’s demon got the best of her.
Group Chief Financial Officer, Chief Operating Officer
Healthcare Consultancy Group
Brian came to HCG 10 years ago through his work with Arthur Andersen LLP as a CPA. While there, he managed business advisory engagements with some of the world’s most prestigious organizations, ranging from consumer packaged goods to advertising firms, including HCG’s parent, Omnicom Group, Inc.
While at Andersen, Brian developed a track record for excelling in client service; he understands the needs of clients, how to cultivate talent, and how to assemble best-in-class teams to deliver efficient, high-value service within each client engagement. Since assuming financial and operational roles within HCG, Brian has drawn on this experience extensively, to the benefit of both his internal and external facing responsibilities as HCG’s CFO, COO.
Today, our clients work closely with Brian in creating value through optimization, efficiency, and the development of new ways of operating. In no industry, perhaps, is this more relevant than in the healthcare sector. Brian has been a partner to both our big pharmaceutical and small biotech clients in overcoming the challenges they increasingly face with regard to financial scarcity and a general de-leveraging of a legacy infrastructure built on the backs of blockbuster, mass market products.
Whether it’s procurement professionals, brand managers, franchise heads, or CEOs, they each are facing the same challenge of accomplishing more with less and optimizing legacy models. In Brian, our clients have found an ally and change agent in creating and maximizing value for both internal and external stakeholders.
Brian’s current passion outside of work centers around everything “kids”. Process optimization and efficiency do not seem to be at the forefront of his 2 small boys’ agenda.
Delphine Dubois, MD, MBA
President, Health Science Communications
Dr. Dubois discovered the exciting world of scientific communications and advertising while working on the launch of Proscar for Merck in France. Following her marketing and advertising experience in Europe, she moved to the US and developed scientific communications for multiple drug launches as a medical director. Before becoming involved with medical education and advertising, Dr. Dubois was a family physician in private practice in Paris. She received her MD degree from the University of Paris, Faculté de Médecine Saint-Antoine. In addition to her medical degree, she also has a master’s degree in business with a specialty in medical marketing from the Ecole Supérieure de Commerce de Paris.
Through her 17 years of experience, she has perfected her ability to build strategic roadmaps for new brands, linking the scientific evidence to the challenging marketplace. Delphine is a master at finding leverage points for her clients. Whether it’s identifying how to best shape the market, mining clinical data to uncover competitive differentiation, or creating programs that generate strong advocacy across the medical/scientific community, she zeroes in on opportunities to best maximize a brand's advantage. She's relentless in her pursuit of smart, strategic solutions, and she lets nothing get in the way of doing what's best for her clients. More than anything, Delphine makes things happen—for her clients, for her agency, and for all who work with her.
Despite her successful career in the US, she will never give up French wine and bread, and celebration of Bastille Day.
Mary Rofael, MD
President, ProEd Communications Inc.
A communications counselor and strategist, Mary Rofael, MD, has more than 20 years’ experience leading medical affairs, publications, and regulatory communications programs for innovative pharmaceutical, medical device, and biotechnology companies.
In the course of this work, Dr. Rofael has led the assessment of drug development plans and data for an extensive portfolio of therapies across numerous therapeutic areas and strategic challenges. She has evaluated data packages to identify and address potential clinical and regulatory hurdles, worked with clients to build credible and compelling messages and presentations, and trained client teams to manage issues and handle objections. She is an experienced facilitator with a focus on moderating communication strategy sessions.
Since 1998, Dr. Rofael served in several positions within ProEd. She founded ProEd’s regularly division and, as Medical Director and Chief Strategic and Regulatory Officer, served as a trusted partner to more than 120 pharmaceutical, biotechnology, and medical device clients as they prepared for FDA Advisory Committee Meetings, EU oral hearings and other critical regulatory interactions. Over 16 years, Dr. Rofael built a team of in-house scientists and regulatory experts, designers and technology specialists, speaker coaches, and program managers who provide full-service support for FDA AdComs and other critical regulatory interactions. As Head of Scientific Services, she provided strategic direction, scientific consulting, and oversight for a division of ProEd that has developed and maintained more than 125 medical publication plans overall, and annually supports the development of more than 350 print and digital projects, including manuscripts, medical abstracts, and posters designed to improve patient outcomes.
Most recently, Dr. Rofael served as Chief Strategic Officer for the Healthcare Consultancy Group (HCG), developing communications strategies and solutions for clients of ProEd and its fellow HCG agencies (Chameleon, Health Science Communications, Hyphen Digital, ProEd Communications, and The Scienomics Group) to address the ever-increasing medical information needs of physicians and patients.
Currently, as President of ProEd Communications Inc., Dr. Rofael directs ProEd’s industry-leading medical affairs, publications, and regulatory communications divisions as well as the firm’s growing market access and development consulting services. She leads teams of MD, PharmD and PhD scientists, client service professionals, designers, and communications coaches to address our clients’ needs across audiences and therapeutic areas.
President, The Scienomics Group
Matt D’Auria brings more than 15 years of strategic marketing and healthcare communications experience to his role as president of The Scienomics Group, where he directs the development and implementation of innovative scientific strategy, medical communications and peer-to-peer education. His clients benefit from his unique blend of marketing expertise, scientific knowledge, and specialty therapeutic area experiences. Matt has worked extensively in oncology, hematology, urology, mental health, and metabolic disorders.
Prior to joining TSG, Matt served as president of an agency specializing in oncology medical communications. He also gained a deep understanding of the industry from a client-side perspective, with prior experience in brand management and sales for AstraZeneca and Solvay Pharmaceuticals. Matt has been involved in branding and commercialization strategies at every point in the drug development life-cycle.
Matt has a profound respect for the science behind today’s innovative medicines. His career began in the laboratory as a bench scientist, studying signal transduction pathways in diabetes mellitus. A graduate of The University of California, Berkeley, with a BS in molecular and cell biology, Matt continued his education and received an executive certificate in pharmaceutical drug development from UC Berkeley’s Haas School of Business.
Matt is a novice wine collector with a particular fondness for a well-aged Barolo. He enjoys cooking and is happiest when his kitchen is full with family and close friends.
Group CEO, Chameleon Communications International, Inc.
+44 (208) 326-3151
Gary is the Group CEO of Chameleon, a leading medical communications company with offices in London, Manchester, and New York. Chameleon specializes in providing leading-edge strategic and advisory services and global and regional communications programs incorporating scientific and marketing communications, professional education, and captivating interactive digital programs, all with the intent to build the scientific platform upon which successful pharmaceutical brands are founded. He believes that effective business leadership is most simply about "positively influencing the course of events" and tries to live up to this day by day.
Gary graduated in physiology and biochemistry from the University of Southampton and found his way into the healthcare arena with Bayer Pharmaceuticals in the UK. Gary progressed through sales and sales management to marketing, where he led the team responsible for the launch of ciprofloxacin (Cipro/Ciproxin). This experience brought Gary into contact with the world of medical communications, and after 11 years at Bayer he moved to Franklin Scientific Projects, a medical education agency within DMB&B where, as managing director, he gained a lifelong interest in helping groups of people excel in achieving their business goals and in growing their business as a result.
Gary brought this philosophy to Chameleon in 2001, via a 2-year spell as CEO of Medical Action Communications. Since then, he has enjoyed the enormous satisfaction of seeing the accumulated hard work and talent of the evolving Chameleon team come to fruition to make it the company it is today.
Chameleon has a range of clients, from small biotech to large pharma, but the common denominator is the passion with which Chameleon identifies the route to success and pursues that goal. Clearly this is highly valued by clients, since loyalty is a theme of Chameleon's client relationships, some of which (Novartis) date back to Chameleon's inception in 1997 and others, such as Bayer, beyond 10 years.
Outside of work, Gary enjoys spending time with his family; watching his football (soccer) team, Tottenham Hotspur; and seeing Bruce Springsteen perform live (no less than 26 times since 1981!).
Jan-Willem van Doorn, MD, PhD, MBA
Executive Vice President, Managing Director, Medical and Scientific
Services, Health Science Communications
Jan-Willem brings broad experience and expertise in the healthcare and life sciences industries to the Healthcare Consultancy Group. He began his career in clinical research in orthopedics after completing his medical degree at the University of Amsterdam. His research culminated in a PhD in medicine from Gothenburg University. Enjoying the business side of medicine, he completed an MBA at NYU’s Stern School of Business with honors (Beta Gamma Sigma). Before making the switch to medical strategy scientific communications, Jan-Willem helped establish The Spine Center at Hospital for Joint Diseases and sharpened his strategic and marketing acumen through management consulting with Booz Allen Hamilton and Campbell Alliance.
Leveraging his broad experience and expertise, Jan-Willem enjoys finding solutions for the diverse and complex challenges our pharmaceutical, biotech, and medical device clients are facing. He takes a holistic approach to issues, weighing the viewpoints of all stakeholders and their importance to create a complete picture. The insights derived this way enable him and his team to develop the best client solutions in a rapidly changing environment. It allows clients to break through their organizational silos and develop integrated solutions for their brands. In pursuit of the best scientific strategy, he follows Michael Porter’s maxim: "The essence of strategy is choosing what not to do."
Jan-Willem leads a large team of in-house medical directors (MDs, PhDs) who are all client-facing and share his passion for excellence in translating the science and developing content of the highest scientific integrity and clinical relevance. The medical directors, deployed in purpose-built teams, work directly with clients to define scientific strategy and communications, and execute programs in compliance with industry standards and regulations. With Jan-Willem at their helm, the medical directors have demonstrated a unique ability to help our clients translate the science of their products and the pathogenesis of associated diseases into clinically relevant and scientifically accurate information understandable by the target audience. Translation of the science is the basis of a scientific platform and development of a scientific brand, and crucial to successful new product launches and life cycle management.
Jan-Willem regularly travels back to his home country, the Netherlands, to visit family, buy Dutch cheese and licorice, and watch his favorite sport, field hockey.
Lauren Pattani-Wright, MBA
Executive Vice President, Managing Director, The Scienomics Group
Lauren brings our clients over 15 years of experience in the healthcare industry, 12 of which she spent on the client-side in marketing, leading a global team to launch compounds in both highly specialized and primary care therapeutic areas. Lauren's launch and post-approval marketing experience includes KOL development, scientific communications, branding and brand positioning, and targeting communication strategy to multiple audiences, including primary care physicians, specialists, patients, and payers.
As head of TSG's San Francisco office, Lauren leads business strategy for our West Coast–based clients, where they benefit significantly from her deep understanding of the healthcare industry and her client-side experience.
Lauren’s biggest passion is the professional development and mentoring of professional women of color; she has spearheaded the Omnicom Women of Color Mentoring Program for the past four years. Lauren received her BA in economics and French at the University of Virginia and her MBA in marketing and finance from Columbia Business School.
President, Hyphen Digital
Greg graduated from Skidmore College, then began his career in digital healthcare communications when he joined WorldMedicalLeaders.com, an Internet start-up company that provides online content to physicians.
One year later he joined the Healthcare Consultancy Group (Hyphen’s parent company) to focus on professional healthcare communications and consulting. At HCG, Greg and his teams have spearheaded the strategy and execution of large and small initiatives for compounds in multiple therapeutic areas before and after launch. His years of experience working with a wide range of pharmaceutical, device, and diagnostic brands as the steward of their overall medical communications strategies provides Greg with a unique holistic perspective that distinguishes him from other leaders in the digital space and positions him to think strategically and not just tactically when it comes to digital.
Greg’s key areas of expertise at HCG include in-depth digital research and strategy solutions to help clients develop effective programs that reach the right audiences through optimal channels, multiplatform interactive content that can be leveraged across appropriate channels, multichannel digital content dissemination for personal and nonpersonal education and promotion, and analytics and metrics to measure the success of existing programs, to optimize future initiatives, and to inform digital strategy and execution.
Greg’s focus is on digital innovation and the integration of digital strategy and solutions into all aspects of healthcare communications. He and the Hyphen team combine technical and healthcare expertise to provide clients with a holistic approach to digital strategy.
In his spare time Greg likes to play golf and squash and is an avid fisherman.
Elizabeth Robinson, EdM
Executive Vice President, Learning and Development
Elizabeth is passionate about education. For 20+ years, she has been committed to creating innovative learning initiatives for clients across therapeutic areas and life cycle stages. After having led some of HCG’s largest accounts and teams, Elizabeth now leverages her learning and leadership skills to attract the best and the brightest talent, to empower individuals and teams to develop to their full potential, and to support HCG’s continuing growth and development as a leading learning organization.
Elizabeth earned her EdM degree in adult learning and leadership from Columbia University’s Teachers College. As a learning scientist, she seeks ways to translate adult learning theory into practice for staff and for clients, with a special focus on design thinking, multiple intelligences (EQ/SQ/CQ), group dynamics, action learning, team learning, and peer coaching.
When not consulting on healthcare education and organizational learning, Elizabeth can be found consulting on wine lists at the Meetinghouse Restaurant in Bedford Village, New York, which she co-owns with her husband, Kevin.
Managing Partner, Executive Creative Director, Choreo Market Access
Roger Haskins has over 20 years of experience developing advertising campaigns and concepts. He began his career in consumer brand advertising at Euro RSCG. For 10 years he designed campaigns for everything from cars (Volvo) to doughnuts (Dunkin’ Donuts). Later, while at Merkeley & Partners he created his favorite work—the rebranding of TicTacs Chills, which you can find at a 7-11 near you.
Roger got his feet wet in pharma advertising on the professional side at Cline Davis & Mann starting in 2003. He worked on the global launch of Pfizer’s Caduet. Shortly after that he moved into Managed Markets at CDM and then Entrée Health, where he worked for 10 years exclusively in the market access space.
With training in fine art and a degree in biology, Roger is a left-brain, right-brain thinker. He is happiest when problem solving both a strategic and creative challenge.
Roger brings his award-winning creative experience to bear across multiple payer and media channels. He knows how to translate market strategies into effective payer communication strategies. His work has gained, improved, and maintained access for a variety of products. He is a firm believer that no matter who the audience is, knowing how to say something can be just as important as what you say.